Colorado Again Confirmed as Top Bioscience State by National Rankings & Venture Capital Funding Activity

Denver, CO -- "It's an exciting time to be a bioscience company in Colorado, and the state is continuing to garner the national attention it deserves for its top-notch bioscience industry," said John Collar, President and CEO of the Colorado BioScience Association (CBSA). "FierceBiotech highlighted Colorado as one of its top five biotech regions, and The Money Tree™ Report, recently released by Genome Technology, listed Colorado in its top 10 Venture Capital deals for both biotech and medical device and equipment."

Colorado's success at attracting venture capital was demonstrated earlier this month when Boulder-based Clovis Oncology, Inc. announced an impressive $145 million in start-up funding at its company launch. Clovis is focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. The company is founded by former executives of Pharmion Corporation, which was acquired by Celgene Corporation in 2008 for $2.9 billion.

"We are so very pleased that the former Pharmion team has chosen to remain in the state and headquarter their new company here. With the experience behind them and the success of the business model from Pharmion, the bioscience industry and Colorado will be keeping a close, and proud, eye on this new start-up," Collar says.

Link to the PR Web Newswire

Boulder Daily Camera Includes CBSA/John Collar Perspective on GlobeImmune & Clovis Announcements

John Collar, CBSA President & CEO, provided perspective to DC Reporter Alicia Wallace on both the recent GlobeImmune and Clovis Oncology announcements.

Link to GlobeImmune signs partnership that could net $500M

Link to Pharmion vets launch new oncology venture

Colorado BioScience Association Featured for Second Time in European Life Science Journal

Link to CBSA's article about the Colorado BioScience industry in the Spring 2009 edition -- look in the USA Section.

Colorado BioScience Assn's Board Chair Rick Jory and Denver's Baxa Corp featured in CBS4 Alan Gionet "Good Question" Feature

Believe It Or Not, There Are Jobs Out There

Good Question: Where are all the jobs?

Written by Alan Gionet

"DENVER (CBS4) ― People showed up early to a jobs.com job fair. There were 75 prospective employers. Not like there used to be, but it was something.

'I have some good skills, I have a lot to offer,' one woman told CBS4. When some employers are reporting hundreds of people applying for a single job, the competition is tough. And some of the potential employers at the job fair, like Adams County government, didn't even have current job openings. It makes you wonder where the jobs are."

Link to the Web article and Video featuring the Colorado BioScience Association's board chair Rick Jory (web and video) and Denver's Baxa Corporation (video only).

Colorado included in May 1 GEN article

Gail Dutton included Colorado in her feature, "Emerging Biotechnology Clusters," in the May 1 Genetic Engineering & Biotechnology News. Here's the paragraph about Colorado:

"Colorado also has strong potential, with continued high levels of state funding for start-up companies and research intuitions. Precommercialization funding grants are capped at $250 million for companies from a five-year, $26.5 million program. Additional funding also is available. Clusters are forming in Denver and Boulder, but the nascent firms tend to be acquired by larger companies before reaching maturity."

Link to read the feature